current treatment options for nsclc without driver mutations
Published 1 year ago • 150 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
47:52
introducing novel immunotherapeutic approaches for metastatic nsclc without driver mutations
-
1:25
current treatment recommendations and future directions for egfr-mutant nsclc
-
2:46
current treatment options for squamous cell lung cancer
-
2:07
increasing treatment options for nsclc
-
1:37
treatment strategies for kras-mutant nsclc with co-mutations
-
3:08
choosing immunotherapy as front line therapy for non-actionable nsclc
-
5:29
the role of driver mutations in nsclc treatment - 2022 program: lcvl
-
7:35
treatment for patients with egfr nsclc - leading developments & current questions in lung cancer
-
6:26
selecting patients for immunotherapy based on driver mutations
-
0:53
future treatment options for squamous cell lung cancer
-
26:33
targeted therapy of lung cancer with or without driver mutations
-
7:57
current treatment landscape for nsclc
-
3:06
current treatment stategies for patients with non-driver nonsquamous nsclc
-
1:46
the evolving treatment landscape for nsclc with egfr exon 20 insertion mutations
-
5:59
targeted therapy in consolidation setting for lung cancer
-
3:30
immunotherapy treatments for non-small cell lung cancer (nsclc)
-
1:00:09
new options for lung cancer therapies
-
1:10
current treatment strategies krasg12c–mutated nsclc
-
6:44
treatment options for lung cancer mutations & contingencies